Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving [Phase 2, Phase 3]

View source ↗

Summary

Cannabidiol is being studied as an adjunct treatment for alcohol use disorder, including withdrawal and craving, in Phase 2 and Phase 3 trials that are not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING